Category - Executive Moves

Executive Moves

Hepion names accomplished life sciences veteran Launa Aspeslet as COO

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Launa Aspeslet, Ph.D., RAC, as chief operating officer to support the company’s rencofilstat clinical program. A versatile C-level executive with more than 25 years of...

June 14, 2022

Executive Moves

Soricimed names scientific, academic leader Dr. Rodney Ouellette to SAB

Rodney Ouellette Soricimed Biopharma appointed one of Atlantic Canada’s leading cancer researchers, Rodney Ouellette, M.D. and Ph.D., to its scientific advisory board. “Rodney has dedicated his life’s work...

June 2, 2022

Executive Moves

MindMed names Schond Greenway as CFO

Schond Greenway Mind Medicine (NASDAQ:MNMD; NEO:MMED) appointed Schond Greenway as CFO. He comes to MindMed with more than 20 years of experience in investment banking, finance and corporate advisory, and investment...

May 24, 2022

Executive Moves

Soricimed Biopharma adds deep public markets experience to team with appointment of healthcare veteran Frank Michalargias as CFO

Frank Michalargias Closely-held Soricimed Biopharma, an oncology drug developer, appointed healthcare industry veteran Frank Michalargias as CFO. In a finance and operations leadership career spanning more than 25...

May 16, 2022

Executive Moves

Qualigen Therapeutics names Shishir Sinha to lead diagnostics division

Shishir Sinha Qualigen Therapeutics (NASDAQ:QLGN) appointed Shishir Sinha, the company’s newly promoted SVP and current COO, to lead its diagnostics division, FastPack. “With the return of the sales and...

April 29, 2022

Executive Moves

Sigyn Therapeutics names hepatology leader Dr. Donald Hillebrand to SAB

Dr. Donald Hillebrand Sigyn Therapeutics (OTC:SIGY) appointed Dr. Donald Hillebrand, M.D., to its scientific advisory board. Dr. Hillebrand is the associate medical director of liver transplantation at Saint...

April 26, 2022

Executive Moves

MindMed names Dr. Francois Lilienthal as CCO

Francois Lilienthal Mind Medicine (NASDAQ, NEO:MNMD) appointed Francois Lilienthal, M.D., as chief commercial officer to support the advancement of the company’s clinical development programs. Dr. Lilienthal has...

April 5, 2022

Executive Moves

RNA Disease Diagnostics adds chief scientific advisor, president to board

Dipanjan Pan RNA Disease Diagnostics (RNADD) appointed its chief scientific advisor, Prof. Dipanjan Pan, Ph.D., and company president, John Erickson, Jr., to the board to further position RNADD to execute the next...

April 4, 2022

Executive Moves

Sigyn Therapeutics names neurology leader Dr. Ajay Verma to SAB

Ajay Verma Sigyn Therapeutics (OTC:SIGY) appointed Ajay Verma, M.D., Ph.D., a recognized thought leader in the field of neurology, to its scientific advisory board. Dr. Verma’s extensive clinical experience and insights...

March 31, 2022

Executive Moves

Eric Cheng rejoins Maxim as head of healthcare investment banking

After an absence of five years, Eric Cheng has rejoined Maxim Group as a senior managing director and head of healthcare investment banking. Mr. Cheng held similar titles at Maxim between 2011 and 2017. Mr. Cheng brings...

March 29, 2022

Category - Executive Moves

Hepion names accomplished life sciences veteran Launa Aspeslet as COO

Soricimed names scientific, academic leader Dr. Rodney Ouellette to SAB

MindMed names Schond Greenway as CFO

Soricimed Biopharma adds deep public markets experience to team with appointment of healthcare veteran Frank Michalargias as CFO

Qualigen Therapeutics names Shishir Sinha to lead diagnostics division

Sigyn Therapeutics names hepatology leader Dr. Donald Hillebrand to SAB

MindMed names Dr. Francois Lilienthal as CCO

RNA Disease Diagnostics adds chief scientific advisor, president to board

Sigyn Therapeutics names neurology leader Dr. Ajay Verma to SAB

Eric Cheng rejoins Maxim as head of healthcare investment banking

General

More